The Dishcast with Andrew Sullivan cover image

The Dishcast with Andrew Sullivan

Johann Hari On Ozempic And Big Food

May 3, 2024
Author Johann Hari discusses Big Food's tactics to get us hooked and the risks of weight-loss drug Ozempic. He shares personal struggles with food, the marketing tactics targeting kids, and the potential dangers of these drugs. The conversation also covers bariatric surgery, past diet drug disasters, and the link between obesity and cancer risk.
58:50

Episode guests

Podcast summary created with Snipd AI

Quick takeaways

  • Weight loss drugs like Ozempic offer significant benefits but come with potential risks and side effects.
  • Psychological impacts of weight loss drugs can surface underlying issues related to overeating habits and emotional connections to food.

Deep dives

Benefits of Weight Loss Drugs Over Bariatric Surgery

Weight loss drugs like Ozempic and Wagovii offer significant weight loss benefits, with an average of 15% of body weight loss in a year, and potentially even higher for the next generation of drugs. These effects are comparable to the weight loss achieved through bariatric surgery, which can lead to substantial health improvements, including reduced risks of heart attacks, cancer, and diabetes-related causes.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode